Gyre Therapeutics Inc (GYRE)

Operating Cash Flow Growth

-1753.02%

TTM · Period ending:

GYRE logo

GYRE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-1753.02%
GYRE TTM Cash from Operations YoY % (62.31% → -1753.02%)
High-resolution chart · PNG

GYRE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Gyre Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-1,753.0217%
163.3006%
126.5092%
67.9809%
-89.3231%
-137.1643%
-114.715%
-96.4399%
-83.5625%
-44.6084%
-18.3798%
329.4749%
217.3732%
165.7574%
137.8754%
67.9663%
46.5152%
32.4477%
-52.149%
-114.9843%
-114.4712%
-123.0946%
-26.2192%
7.8859%
12.5821%
12.9127%
-52.744%
-72.2224%
-78.646%
-85.0349%
-43.1946%
-39.0269%
-26.5495%
-15.1776%
-7.9472%
0.1985%
-6.342%
7.1852%
3.379%
-9.4491%
14.1385%
19.3863%
44.5582%
60.0272%
53.9206%
47.8001%
15.0916%
-3.7861%
-6.9408%
5.181%
36.7798%
43.9023%
48.3716%
43.7943%
23.2674%
7.2697%
-3.9005%
-49.0171%
-160.5345%
-155.4542%
-148.2579%
-136.8008%
669.8076%
919.0349%
683.5866%
638.2056%
14.1184%
25.9879%
-1,791.7441%
-841.1699%
-213.781%
-214.3113%
393.8455%
170.5597%
351.0855%
284.3667%
95.9454%
108.897%
62.3101%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.